Why the study?
Does a DCB-only PCI strategy combined with SAPT reduce post-PCI bleeding risk in patients with CAD and HBR compared to stenting?
Does a DCB-only PCI strategy combined with SAPT reduce post-PCI bleeding risk in patients with CAD and HBR compared to stenting?
A DCB-only PCI strategy combined with SAPT is a novel approach that could reduce post-PCI bleeding risk in patients with CAD and HBR compared to traditional stenting.
May support DCB-only PCI with SAPT in high-bleeding-risk CAD; leaves open randomized confirmation versus stenting.
Despite the aged patient population with comorbidities, the TLR, MACE, and bleeding rates were low with DCB-only PCI combined with SAPT. This novel approach could reduce the post-PCI bleeding risk in patients with CAD and HBR compared to stenting.
No takes yet. Share an insight, caveat, or question.
Räsänen et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: